Methylprednisolone Acetate — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Methylprednisolone Acetate. We track 24 distinct Drug Identification Numbers (DINs) for this molecule, of which 7 are currently in marketed status. Across those registrations there are 11 manufacturers or marketing authorization holders, 3 dosage forms, and 4 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Methylprednisolone Acetate in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Methylprednisolone Acetate product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Methylprednisolone Acetate
Dosage forms: Suspension, Lotion, Cream. Strengths: 40 MG, 80 MG, 20 MG, 2.5 MG.
Manufacturers and marketing authorization holders
CENTRAL SALES LIMITED, PFIZER CANADA ULC, ZOETIS CANADA INC, PHARMACIA ANIMAL HEALTH, AYERST VETERINARY LABORATORIES, SANDOZ CANADA INCORPORATED, PROFESSIONAL VETERINARY LABORATORIES, VETCOM 1979 INC., TARO PHARMACEUTICALS INC, UNIVET PHARMACEUTICALS LTD., VETOQUINOL N A INC.
Registered products containing Methylprednisolone Acetate
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 00517097 | CENTRA MEDRIN | CENTRAL SALES LIMITED | 40 MG | Suspension | Cancelled Post Market |
| 01934333 | DEPO-MEDROL | PFIZER CANADA ULC | 40 MG | Suspension | Marketed |
| 00828920 | DEPO-MEDROL | ZOETIS CANADA INC | 40 MG | Suspension | Marketed |
| 00030767 | DEPO-MEDROL | PFIZER CANADA ULC | 80 MG | Suspension | Marketed |
| 01934325 | DEPO-MEDROL | PFIZER CANADA ULC | 20 MG | Suspension | Marketed |
| 00030759 | DEPO-MEDROL | PFIZER CANADA ULC | 40 MG | Suspension | Marketed |
| 01934341 | DEPO-MEDROL | PFIZER CANADA ULC | 80 MG | Suspension | Marketed |
| 00828912 | DEPO-MEDROL STERILE AQUEOUS SUSPENSION 20MG/ML | PHARMACIA ANIMAL HEALTH | 20 MG | Suspension | Cancelled Post Market |
| 00260428 | DEPO-MEDROL WITH LIDOCAINE | PFIZER CANADA ULC | 40 MG | Suspension | Marketed |
| 00712671 | DEPOCOID 40 | AYERST VETERINARY LABORATORIES | 40 MG | Suspension | Cancelled Post Market |
| 00252395 | MEDROL ACNE LOTION | PFIZER CANADA ULC | 2.5 MG | Lotion | Cancelled Post Market |
| 00031062 | MEDROL TOPICAL 0.25% | PFIZER CANADA ULC | 2.5 MG | Cream | Cancelled Post Market |
| 02245406 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | 80 MG | Suspension | Cancelled Post Market |
| 02245400 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | 40 MG | Suspension | Cancelled Post Market |
| 02245408 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | 80 MG | Suspension | Cancelled Post Market |
| 02245407 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(40MG/ML WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | 40 MG | Suspension | Cancelled Post Market |
| 00386847 | METHYLPREDNISOLONE ACETATE SUS 40MG/ML | PROFESSIONAL VETERINARY LABORATORIES | 40 MG | Suspension | Dormant |
| 00460192 | METHYSONE INJ 40MG/ML | VETCOM 1979 INC. | 40 MG | Suspension | Cancelled Post Market |
| 00194867 | NEO-MEDROL | PFIZER CANADA ULC | 2.5 MG | Cream | Cancelled Post Market |
| 00195057 | NEO-MEDROL ACNE LOTION | PFIZER CANADA ULC | 2.5 MG | Lotion | Cancelled Post Market |
| 02518139 | TARO-METHYLPREDNISOLONE INJECTION | TARO PHARMACEUTICALS INC | 80 MG | Suspension | Approved |
| 02518120 | TARO-METHYLPREDNISOLONE INJECTION | TARO PHARMACEUTICALS INC | 40 MG | Suspension | Approved |
| 00552968 | UNI-MED INJ 40MG/ML | UNIVET PHARMACEUTICALS LTD. | 40 MG | Suspension | Cancelled Post Market |
| 02011689 | VETACORTYL | VETOQUINOL N A INC | 40 MG | Suspension | Cancelled Post Market |
Sourcing Methylprednisolone Acetate through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Methylprednisolone Acetate we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Methylprednisolone Acetate and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.